CVS Pharmacy has pulled Zantac from its shelves due to a concern that the medication might contain a substance that causes cancer, reports said.

'This action is being taken out of an abundance of caution,' says CVS

The FDA said people shouldn't panic, but suggests switching to another over-the-counter drug while the agency tests more samples

CVS Pharmacy says it is pulling the heartburn medication Zantac from its shelves over traces of a substance with a possible link to cancer. CBSN New York reports.

Bangladesh's drug regulatory authority on Sunday issued a ban on sales of popular heartburn drug ranitidine while it investigates a potential cancer-causing substance in the drug.

CVS pharmacies become the latest to withdraw Zantac, a drug being investigated for cancer links.

An explosive whistleblower complaint and President Trump. It's Thursday's news.

Health Canada said on Wednesday four companies were recalling popular heartburn drug ranitidine, known by its brand name Zantac, after presence of a probable cancer-causing impurity was found in some of the drugs.

Days after drugmakers and global public health regulators claim to have taken steps to remove supplies of a popular heartburn medication currently under invesigation by US-Food and Drug Administration

A carcinogen ID'd in recalled losartan tablets is the same one that prompted Novartis to halt distribution of generic Zantac meds

Versions of the drug have been found to contain low levels of a carcinogen. But it’s still on pharmacy shelves. Here’s what you need to know.

A division of Novartis is reportedly halting distribution of generic Zantac pills amid concerns about an ingredient possibly linked to cancer.

A version of a popular heartburn medicine is now on hold. There are concerns that the generic version of the drug known as Zantac may cause cancer. Novartis stopped the distribution of its prescription version as a precaution. The move comes after the FDA ann…

The maker of a generic version of Zantac is halting distribution. It comes after an FDA warning about a possible cancer-causing chemical found in Zantac and related heartburn medications. Dr. Jon LaPook explains.

Novartis said it's conducting its own investigation into traces of a potentially cancer-causing ingredient in Zantac

Novartis said it's conducting its own investigation into traces of a potentially cancer-causing ingredient in Zantac

Drug maker halts distribution of its versions of the drug commonly known as Zantac in all its markets, including Canada and the U.S., after contaminants were found in the heartburn drug.

Novartis AG's Sandoz unit said on Wednesday it was halting distribution of its versions of the drug commonly known as Zantac in all its markets, including the United States and Canada, after contaminants were found in the heartburn drug.

U.S. agency found low levels of a "probable" cancer-causing chemical in Zantac and generic heartburn medications

U.S. agency found low levels of a "probable" cancer-causing chemical in Zantac and generic heartburn medications

Small amounts of a cancer-causing chemical have been found in the popular heartburn medication Zantac, as well is in generic forms of the drug, known as Ranitidine. The FDA is not issuing a recall and says patients can continue taking the medication. Zantac's…

The FDA issued an alert that Zantac and its generic versions contain low levels of a probable human carcinogen called NDMA, but it is not calling for individuals to stop taking the drug as the agency continues to investigate.

Happy Friday, readers. In 2018, Moderna Therapeutics filed for a titanic IPO (at that point, the largest biotech public offering in history). It raised $604 million, setting the company up for an initial valuation of about $7.5 billion. But, as is the story w…

The Food and Drug Administration is investigating levels of a contaminant in popular heartburn medication Zantac and related generic drugs.

U.S. agency found low levels of a "probable" cancer-causing chemical in Zantac and generic heartburn medications

First U.S. trial over Zantac's alleged cancer-causing properties to begin in November. Outcome could influence broader settlement negotiations. #Zantac #GSK #Sanofi #Pfizer #BoehringerIngelheim #negative https://t.co/PLGEfCvYc1

First trial over heartburn drug Zantac cancer claims expected in November #GSK #zantac #heartburndrug #cancer #ranitidine #sanofi #pfizer #boehringeringelheim https://t.co/aVoQwKvrLL

Health News Roundup: Organon, Samsung Bioepis launch copycat for arthritis drug Humira at 85% discount; First trial over Zantac cancer claims set for November https://t.co/hANNjtqYWN

RT @Amothersanthem: For those who know there is more to the story of Covid-19 vaccine safety than we are told, take a look at this case. Ca…

Health News Roundup: First trial over Zantac cancer claims set for November; Sandoz launches rival version of AbbVie's arthritis drug Humira and more https://t.co/dFDea82yz3

RT @pharmalot: GSK settles first lawsuit set for a U.S. trial over cancer links to Zantac.. https://t.co/7ebFAENgHe #pharma #Zantac $GSK $S…

RT @weldeiry: First trial over Zantac cancer claims set for November Plaintiffs in the litigation claim that Zantac causes nine forms of c…

First trial over Zantac cancer claims set for November Plaintiffs in the litigation claim that Zantac causes nine forms of cancer, including colorectal, breast and bladder cancer. https://t.co/CqUzcRRLDL

RT @evangrizlon: Lana del Rey in the morning, boyfriend take warning... Lana del Rey at night, boyfriends delight

The first U.S. trial over claims that discontinued heartburn drug Zantac causes cancer is now expected to take place in California state court on Nov. 13, a lawyer for plaintiffs in the litigation said Friday. https://t.co/WspU0YXsqb

RT @cohkohhh: In 1983 the FDA approved Zantac. In 2020, the FDA asked for Zantac to be pulled from the shelves because it contains a cancer…

GSK settles first lawsuit set for a U.S. trial over cancer links to Zantac https://t.co/MTYjyerhoo via @statnews #healthcare

RT @cmencke: AwesomeCapital: First trial over Zantac cancer claims set for Nove... https://t.co/L14pin0P77

AwesomeCapital: First trial over Zantac cancer claims set for Nove... https://t.co/L14pin0P77

Thousands of US Lawsuits Against Zantac - Claim It Causes 9 Cancers https://t.co/OURueEeBlr

RT @CaptJawed: "First trial over #Zantac cancer claims set for November". https://t.co/YY9lCKtFZg

"First trial over #Zantac cancer claims set for November". https://t.co/YY9lCKtFZg

RT @Spilling_The_T: Me sitting by myself watching Trixie and Katya talk to each other https://t.co/3lvUn12rJL

RT @chitraSD: #Cancer patient wins. #GSK loses. https://t.co/pMtTj4xzs0

Zantac was a popular heartburn medication that was withdrawn from the market in 2020 after it was found to contain NDMA, a probable human carcinogen. GSK and other companies that made it has been facing lawsuits from people who claim that the drug caused them to develop cancers

RT @colmant_: GSK settles first lawsuit set for a trial over cancer links to Zantac https://t.co/IZN4C2ZFBs

GSK settles first lawsuit set for a trial over cancer links to Zantac https://t.co/IZN4C2ZFBs

JPMorgan - $GSK announced that they have agreed an undisclosed Zantac settlement with James Goetz, the plaintiff for the first bellwether case in California. This morning’s update removes the immediate headline risk around the first bellwether in July.

RT @statnews: GSK reached a settlement with a man who claimed its Zantac heartburn medication caused his cancer, avoiding the first such ca…

RT @WisnerBaum: Wisner Baum and @MooreLawGroupKY have negotiated a settlement of the first Zantac case set to go to trial in California. On…

RT @statnews: GSK reached a settlement with a man who claimed its Zantac heartburn medication caused his cancer, avoiding the first such ca…

RT @chitraSD: #Cancer patient wins. #GSK loses. https://t.co/pMtTj4xzs0

#Cancer patient wins. #GSK loses. https://t.co/pMtTj4xzs0

#GSK #reaches first #legal #settlement over #heartburn #medicine #Zantac https://t.co/5RMEY3p342

RT @statnews: GSK reached a settlement with a man who claimed its Zantac heartburn medication caused his cancer, avoiding the first such ca…

RT @statnews: GSK reached a settlement with a man who claimed its Zantac heartburn medication caused his cancer, avoiding the first such ca…

GSK reached a settlement with a man who claimed its Zantac heartburn medication caused his cancer, avoiding the first such case that was about to go to trial in the U.S. https://t.co/wEiSrrXY4E

RT @CityAM: GSK said the claims were “meritless” and that scientific evidence from 11 studies shows there is no cancer risk in the drug. h…

GSK said the claims were “meritless” and that scientific evidence from 11 studies shows there is no cancer risk in the drug. https://t.co/8FQNMsYwto

GSK settles key Zantac cancer lawsuit https://t.co/6eQ9B5h7Vu

RT @WisnerBaum: Wisner Baum and @MooreLawGroupKY have negotiated a settlement of the first Zantac case set to go to trial in California. On…

What's your handle? I need a Zantac, ahk And thanks before I blank into anaphylactic shock Rock or disco, chocolate on a Crisco ho Cock diesel and still tell a joke like Joe Piscopo Tell 'em the basics, basically, break the matrix And just for kicks, make 'em gel like Asics

RT @annaedney: It's a good time to repost this investigation from @susanberfield, Jef Feeley and I earlier this year https://t.co/4RYx9hAv1j

RT @RynOrion: @livewithmecfs Just be aware - the article is 3.5 years old. The “Z-Z Protocol” of an H1 and an H2 blocker - Zyrtec and Zanta…

How is the secrets revealed better than part three of the reunion???? if production had a half a brain, they would release six more episodes of this. It’s juicy.